Intra Cellular Therapies | Leverandørgjeld

Created with Highcharts 10.1.0Chart context menu


Trade Creditors Endring Dato
Acadia Pharmaceuticals USD 16.19M 2.89M 2024-12
ALKERMES USD 45.63M 8.59M 2024-12
Biogen USD 424.2M 1.5M 2024-12
Bristol-Myers Squibb USD 3.6B 133M 2024-12
Cytokinetics USD 20.37M 8.79M 2024-12
Gilead Sciences USD 833M 70M 2024-12
Halozyme Therapeutics USD 10.25M 2.15M 2024-12
Intra Cellular Therapies USD 26.07M 15.74M 2024-12
J&J USD 10.31B 1.36B 2024-12
Neurocrine Biosciences 110M 282.7M 2024-12
Novartis USD 4.57B 485M 2024-12
Prothena USD 7.77M 2.56M 2024-12
RedHill Biopharma USD 1.91M 0 2024-06
Supernus Pharmaceuticals USD 4.59M 1.8M 2024-12
United Therapeutics 6M 357.9M 2024-12



Intra Cellular Therapies Leverandørgjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.